Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
January 4, 2019
[Empirical health services research in emergency and acute medicine : Preliminary results of concomitant monitoring of patient recruitment and sample quality]
V Krobisch, J Deutschbein, M Möckel, et al.
JTO Clinical and Research Reports
|
August 13, 2025
Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors
Alexander S Watson, Alyse W Staley, Benjamin Yoder, et al.
Cell Death and Differentiation
|
January 14, 2017
The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection
Selma Tuzlak, Robyn L Schenk, Ajithkumar Vasanthakumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 11, 2020
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation
Terry L Ng, Amber Johnson, Raphael A Nemenoff, et al.
Advances in Radiation Oncology
|
June 13, 2024
The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer
David Chun Cheong Tsui, Douglas E Holt, Tejas Patil, et al.
JTO Clinical and Research Reports
|
August 18, 2025
Role of Quality of Life in Daily Functioning, Communication with Care Teams, and Treatment Decisions in Patients with <i>ALK</i>+ NSCLC
Heather Law, Huamao M Lin, Eileen Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3
Natasha B Leighl, Nofisat Ismaila, Greg Durm, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2008
Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo
Suresh Radhakrishnan, Rosalyn Cabrera, Erin L Schenk, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 22, 2023
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer
Jacob Langston, Tejas Patil, D Ross Camidge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1
Lyudmila Bazhenova, Nofisat Ismaila, Greg Durm, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
January 4, 2019
[Empirical health services research in emergency and acute medicine : Preliminary results of concomitant monitoring of patient recruitment and sample quality]
V Krobisch, J Deutschbein, M Möckel, et al.
JTO Clinical and Research Reports
|
August 13, 2025
Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors
Alexander S Watson, Alyse W Staley, Benjamin Yoder, et al.
Cell Death and Differentiation
|
January 14, 2017
The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection
Selma Tuzlak, Robyn L Schenk, Ajithkumar Vasanthakumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 11, 2020
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation
Terry L Ng, Amber Johnson, Raphael A Nemenoff, et al.
Advances in Radiation Oncology
|
June 13, 2024
The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer
David Chun Cheong Tsui, Douglas E Holt, Tejas Patil, et al.
JTO Clinical and Research Reports
|
August 18, 2025
Role of Quality of Life in Daily Functioning, Communication with Care Teams, and Treatment Decisions in Patients with <i>ALK</i>+ NSCLC
Heather Law, Huamao M Lin, Eileen Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3
Natasha B Leighl, Nofisat Ismaila, Greg Durm, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2008
Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo
Suresh Radhakrishnan, Rosalyn Cabrera, Erin L Schenk, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 22, 2023
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer
Jacob Langston, Tejas Patil, D Ross Camidge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1
Lyudmila Bazhenova, Nofisat Ismaila, Greg Durm, et al.
Page
of 11